Technologies related to Therapeutic (biologic)

Title
Encapsulated Streptococcus Compositions and Methods for Pneumococcal Vaccine, Probiotic, and Diagnostic Assay Development
Ref: E-009-2018-0 | Updated: Feb 26, 2019
Human Retrovirus Obtained from Infected Chimpanzee Exposure
Ref: E-251-2013-0 | Updated: Sep 10, 2018
Licensing Availability: Methods of Diagnosing and Treating CHAPLE, A Newly Identified Orphan Disease
Ref: E-251-2016-0 | Updated: Sep 7, 2018
New Anti-Influenza Virus Neuraminidase 9 (N9) Monoclonal Antibody – for Prevention or Treatment of H7N9 Influenza (Flu) A with Less Likelihood of Drug Resistance
Ref: E-200-2016-0 | Updated: Jun 20, 2018
Novel Fourth Human Ebolavirus species, Bundibugyo ebolavirus – Compositions and Methods for Vaccine, Therapeutics and Highly Sensitive Diagnostic Assay Development
Ref: E-159-2013-0 | Updated: Jun 7, 2018
Heartland Virus Humanized Monoclonal Antibodies for Diagnostic and Therapeutic Development
Ref: E-293-2014-1 | Updated: Feb 14, 2018
Heartland Virus Humanized Monoclonal Antibodies for Diagnostic and Therapeutic Development
Ref: E-293-2014/1 | Updated: Feb 14, 2018
Regenerative Therapy for Cartilage Damage
Ref: E-152-2017-0 | Updated: Jan 25, 2018
Neutralizing Antibodies to Influenza HA and Their Use and Identification
Ref: E-061-2016-0 | Updated: Jun 22, 2018
Chimeric Antibodies Against Hepatitis B e-Antigen
Ref: E-192-2017/0 | Updated: Jan 31, 2018
Chimeric Antibodies Against Hepatitis B e-Antigen
Ref: E-192-2017-0 | Updated: Jan 31, 2018
Efficient mRNA-Based Genetic Engineering of Human NK Cells with High-Affinity CD16 and CCR7
Ref: E-036-2015-0 | Updated: May 17, 2017
T-cells Transduced with HLA A11 restricted CT-RCC HERV-E reactive TCR to Treat Patients with ccRCC
Ref: E-120-2016-0 | Updated: May 17, 2017
cGAP-PNA Multivalent Ligand Display at the Nanoscale
Ref: E-761-2013/0 | Updated: Apr 18, 2017
Monoclonal Antibodies that Neutralize Norovirus
Ref: E-226-2011-0 | Updated: May 16, 2018
Use of Roseomonas Species to Treat Eczematous (Atopic Dermatitis) Skin Disease
Ref: E-099-2016-0 | Updated: Oct 27, 2016
Capsid-Free AAV Vectors for Gene Delivery and Their Use for Gene Therapy
Ref: E-241-2010/0 | Updated: Oct 12, 2016
Long Acting Therapeutic Conjugates with Evans Blue
Ref: E-143-2015/0 | Updated: Jun 27, 2016
Tagged Form of Mut Enzyme and Its Use in Gene Therapy
Ref: E-090-2015/0 | Updated: Apr 18, 2016
Gene Therapy for Niemann-Pick Disease Type C
Ref: E-185-2014/0 | Updated: Apr 18, 2016
Fetal Hemoglobin Induction for Treating Sickle Cell Disease and Thalassemias
Ref: E-038-2016-0 | Updated: May 10, 2018
TRPC Knockout (KO) Mice and Mice with a Floxed Allele of TRPC Ion Channel Genes
Ref: E-071-2014-2 | Updated: May 14, 2018
Mice with a Floxed Allele of the alpha Subunit of the Heterotrimeric G Protein Go or Gi2
Ref: E-071-2014-0 | Updated: May 14, 2018
Mouse Model for Study of Diabetic Nephropathy and Role of Soluble Epoxide Hydrolase
Ref: E-292-2015-0 | Updated: May 24, 2016
Enhancing Adoptive T Cell Therapy Using c-Myb
Ref: E-232-2015-0 | Updated: Nov 4, 2015
Modified AAV5 Vectors for Enhanced Transduction and Reduced Antibody Neutralization
Ref: E-097-2015-0 | Updated: May 1, 2019
Novel Treatment for Anemia and Polycythemia: AVPR1B Molecules Modulating Erythropoiesis
Ref: E-619-2013-0 | Updated: Aug 6, 2015
A Novel Adeno-Associated Virus for Gene Therapy
Ref: E-175-2015-0 | Updated: May 1, 2019
Bispecific Chimeric Antigen Receptors to CD22 and CD19 for Treating Hematological Cancers
Ref: E-106-2015-0 | Updated: Aug 22, 2018
Device for Selective Partitioning of Frozen Cellular Products
Ref: E-173-2009/0 | Updated: Jun 29, 2015
A Novel Therapeutic Vector for Hemoglobin Disorders
Ref: E-165-2014-0 | Updated: Sep 21, 2015
IFN Gamma for Reducing Adverse Ocular Side Effects of MEK-Inhibitor Therapy in Cancer
Ref: E-248-2012/0 | Updated: Jul 1, 2015
CXCR4 Reduction Leads to Enhancement of Engraftment of Hematopoietic Stem Cells
Ref: E-173-2014/0 | Updated: Jul 1, 2015
T-cell Chimeric Receptors of TSLPR for Diagnosis and Immunotherapy of Cancer
Ref: E-008-2014-0 | Updated: Nov 20, 2014
The Use of Chimeric Antigen Receptor to Control HIV Infection
Ref: E-212-2014/0 | Updated: Sep 9, 2015
Chimeric Receptors Targeting CD-19
Ref: E-042-2014-0 | Updated: Oct 28, 2014
A Novel Fusion Protein for Inhibiting HIV Budding
Ref: E-223-2014-0 | Updated: May 10, 2018
Monitoring the Effects of Sleep Deprivation Using Neuronal Avalanches
Ref: E-345-2013/0 | Updated: Aug 17, 2016
AAV-Vectors for Treatment of Glycogen Storage Disorders
Ref: E-552-2013-0 | Updated: Aug 6, 2014
Polypeptides and Methods for Enhancing and Balancing Monovalent or Multivalent Flavivirus Vaccines
Ref: E-275-2013-0 | Updated: Aug 23, 2018
Treatment of Chronic Kidney Disease with Synthetic Amphipathic Peptides
Ref: E-743-2013/0 | Updated: Jun 2, 2014
Discrete Cross-Reactive Epitopes for Flavivirus Serological Diagnostics and Vaccines
Ref: E-333-2013/0 | Updated: May 15, 2014
MDCK-based Reporter System for Detection of Influenza Viruses, Antiviral Drug Screening, and Analysis of Neutralizing Antibodies
Ref: E-185-2013/0 | Updated: May 15, 2014
Multi-specific Chimeric Antigen Receptors Against HIV
Ref: E-170-2013/0 | Updated: Oct 23, 2017
Compositions for Modification of Genomic DNA and Exogenous Gene Expression
Ref: E-763-2013-0 | Updated: May 14, 2018
Engineering Neural Stem Cells Using Homologous Recombination
Ref: E-762-2013-0 | Updated: May 14, 2018
Role of Novel Hepatitis Delta Virus Variant in Sjogren’s Syndrome
Ref: E-736-2013-0 | Updated: Apr 14, 2014
Human iPSC-Derived Mesodermal Precursor Cells and Differentiated Cells
Ref: E-342-2013-0 | Updated: May 14, 2018
Dengue Vaccines: Tools for Redirecting the Immune Response for Safe, Efficacious Dengue Vaccination
Ref: E-289-2013-0 | Updated: Mar 18, 2014
Rabies Vaccine for the Oral Immunization of Domesticated Animals, Wildlife and Feral Animals
Ref: E-470-2013/0 | Updated: May 24, 2016
Methods for Amelioration and Treatment of Pathogen-associated Inflammatory Response
Ref: E-236-2013/0 | Updated: Feb 19, 2014
Recombinant Sulfated HIV Envelope Protein and Methods for Making Protein
Ref: E-067-2012/0 | Updated: Apr 15, 2014
Peptide Sequences for Chlamydophila pneumoniae Vaccine and Serological Diagnosis
Ref: E-235-2013/0 | Updated: Feb 7, 2014
CD40 Ligand: Adjuvant for Enhanced Immune Response to Respiratory Syncytial Virus
Ref: E-233-2013/0 | Updated: Feb 6, 2014
Recombinant Polypeptides for Clinical Detection of Taenia solium and Diagnosis of Cysticercosis
Ref: E-230-2013/0 | Updated: Feb 6, 2014
Therapeutic, Bifunctional Janus Microparticles with Spatially Segregated Surface Proteins and Methods of Production
Ref: E-457-2013/1 | Updated: Jan 28, 2014
Virus Replicon Particles as Rift Valley Fever Vaccines
Ref: E-272-2013/0 | Updated: Aug 8, 2016
Vaccine Attenuation via Deoptimization of Synonymous Codons
Ref: E-328-2013-0 | Updated: Jan 28, 2014
Multi-Antigenic Peptide(s) Vaccine and Immunogen for Conferring Streptococcus pneumoniae Immunity
Ref: E-248-2013/1 | Updated: Jan 27, 2014
Select M. tuberculosis Peptides as Mucosal Vaccines Against Pulmonary Tuberculosis
Ref: E-192-2013/0 | Updated: Jan 27, 2014
Exposure and Activity Detection Assays for Anthrax Lethal Factor and Lethal Toxin
Ref: E-196-2013/0 | Updated: Mar 3, 2017
Virus Microneutralization Assay Data Analysis for Vaccine Development, Enhancement and Efficacy Improvement
Ref: E-262-2013/0 | Updated: Jan 27, 2014
Immunogenic Hepatitis E Virus Polypeptides for Vaccine and Diagnostics Development
Ref: E-152-2013/0 | Updated: Jan 20, 2014
Respiratory Syncytial Virus Immunogens for Vaccine and Therapeutics Development
Ref: E-197-2013/0 | Updated: Jan 16, 2014
Novel Primate T-cell Lymphotropic Viruses (HTLV, STLV) for Development of Diagnostics, Therapeutics, Research Tools, and Vaccines
Ref: E-281-2013/0 | Updated: May 24, 2016
Methods of Treating or Preventing Pruritis (Itch)
Ref: E-485-2013 | Updated: May 31, 2018
Methods of Treating or Preventing Pruritis (Itch)
Ref: E-485-2013-0 | Updated: Jun 7, 2018
Diisocyanate Specific Monoclonal Antibodies for Occupational and Environmental Monitoring of Polyurethane Production Exposure-related Asthma and Allergy and Clinical Diagnosis
Ref: E-189-2013/0 | Updated: Jan 23, 2014
Chimeric Antigen Receptors to CD276 (B7-H3) for Treatment of Cancer
Ref: E-104-2013-0 | Updated: Aug 22, 2018
Human Rotavirus Strains and Vaccines for Neonatal Childhood Protection
Ref: E-150-2013-0 | Updated: Feb 13, 2014
Novel Epitopes of Bacillus anthracis Lethal Factor for Development of Diagnostics and Therapeutics
Ref: E-210-2013/0 | Updated: Mar 3, 2017
Diagnostics, Vaccines, and Delivery-Vehicles Related to Novel Phlebovirus
Ref: E-269-2013/0 | Updated: Dec 4, 2013
Intranasal Nebulizer with Disposable Drug Cartridge for Improved Delivery of Vaccines and Therapeutics
Ref: E-308-2013-0 | Updated: Jun 14, 2018
Broadly Neutralizing Human Anti-HIV Monoclonal Antibody 10E8 and Related Antibodies Capable of Neutralizing Most HIV-1 Strains
Ref: E-253-2011/0 | Updated: Jun 18, 2014
Novel Regulatory B cells for Treatment of Cancer and Autoimmune Disease
Ref: E-101-2010/0 | Updated: Sep 21, 2015
Use of a Modified Adaptor Molecule LAT to Improve Immunotherapy for Cancer and Other Diseases
Ref: E-159-2009/0 | Updated: Oct 23, 2017
Therapeutic Peptide Treatment for Dyslipidemic and Vascular Disorders
Ref: E-138-2008-0 | Updated: Aug 8, 2016
Targeted Delivery of siRNA
Ref: E-051-2008/0 | Updated: Oct 10, 2017
ApoA-1 Mimetic Peptides Promoting Lipid Efflux from Cells for Treatment of Vascular Disorders
Ref: E-114-2004-0 | Updated: Nov 29, 2016
Anti-Marinobufagenin Antibodies and Methods for Diagnosis and Treatment of Cardiovascular Disease
Ref: E-092-2004/0 | Updated: Jun 29, 2017
Novel Methods for Reducing Inflammation and Treating Diseases such as Parkinson's and Alzheimer's Disease
Ref: E-130-2004-0 | Updated: May 4, 2018
Oral Treatment of Hemophilia
Ref: E-281-2001/0 | Updated: Dec 4, 2013
Subscribe to Technologies related to Therapeutic (biologic)